Single gene or panel testing – how can we balance clinical value and timely reporting?

In this presentation aimed at Cancer MDTs, Dr Mike Hubank and Dr Gareth Gerrard provide an overview of the cancer diagnostic tests available in England and the evolving role of panel testing and single/low number gene testing.

Dr Mike Hubank is Scientific Director North Thames GLH, and Dr Gareth Gerrard is Lead Scientist for Cancer Genomics South East GLH.

This was recorded in September 2022 as part of the Bayer sponsored educational event Everything you want to know about genomics but are afraid to ask, which explored the benefits and challenges of mainstreaming genomic profiling and precision oncology pathways in the management of patients with cancer.

You can view the other presentations from the meeting by following the links below;